Rodney Nussbaum - Mar 20, 2024 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
Director
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Rodney Nussbaum
Stock symbol
GYRE
Transactions as of
Mar 20, 2024
Transactions value $
$0
Form type
4
Date filed
3/21/2024, 08:31 PM
Next filing
Aug 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Award $0 +1.87K $0.00 1.87K Mar 20, 2024 Common Stock 1.87K $17.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest as to one-third on each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service to the Issuer through each vesting date.